Patents Assigned to UNIVERSITA' DEGLI STUDI DELLA BASILICATA
  • Selective agonists of beta-adrenergic type 3 receptors (BAR3) and use thereof
    Patent number: 10149837
    Abstract: Object of the present invention is the use of selective agonists of beta-adrenergic type 3 receptors (BAR3) in the treatment of nephrogenic diabetes insipidus (NDI), in particular of X-linked nephrogenic diabetes insipidus (X-NDI).
    Type: Grant
    Filed: September 23, 2015
    Date of Patent: December 11, 2018
    Assignees: UNIVERSITA' DEGLI STUDI DI BARI, UNIVERSITA' DEGLI STUDI DELLA BASILICATA, UNIVERSITA' DEGLI STUDI DI PISA
    Inventors: Maria Svelto, Giuseppe Procino, Monica Carmosino, Massimo Dal Monte, Paola Bagnoli